<DOC>
	<DOCNO>NCT02304783</DOCNO>
	<brief_summary>Outpatients treatment NSAI renal colic well investigate clear recommendation regard matter . The aim study determine oral NSAI treatment beneficial patient discharge emergency departement first line treatment renal colic investigate recurrence pain , reconsultation rate admission .</brief_summary>
	<brief_title>Oral NSAI Versus Placebo Second Line Treatment Renal Colics</brief_title>
	<detailed_description>Renal colic ( RC ) frequent cause consultation emergency departement ( ED ) . They count approximatively 20 % patient present ED severe acute onset abdominal pain . The first line treatment renal colic base NSAI drug associate antalgics investigate NSAI v Morphine study ( NCT02156596 ) . But clear recommendation regard outpatient treatment renal colic . Oral NSAI still widely use second line medicine condition variety molecule try solid scientific argument . Piroxicam , non-selective COX inhibitor drug appared Oxicam class NSAI , widely use treat rheumatoid condition inflammatory condition often prescribe Tunisia second line treatment RC . In study , aim investigate efficiency safety use oral NSAI drug ( Piroxicam ) compare placebo second line treatment renal colic .</detailed_description>
	<mesh_term>Colic</mesh_term>
	<mesh_term>Renal Colic</mesh_term>
	<mesh_term>Piroxicam</mesh_term>
	<criteria>Over 16 year old Consenting participate study Patients treat ED RC No contraindication NSAI treatment Patients exclude first phase study Contraindication NSAI treatment Patients non reachable telephone call Patients receive use treatment</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Renal colic , Piroxicam</keyword>
</DOC>